In vitro modulation by TLR8 agonist GS-9688 of multiple regulatory cell types in patients with chronic hepatitis B

被引：1
|
作者：
Amin, Oliver E. [1 ]
Colbeck, Emily [1 ]
Daffis, Stephane [2 ]
Pattabiraman, Divya [2 ]
Sitali, Colette [3 ]
Rosenberg, William [3 ]
Fletcher, Simon [2 ]
Maini, Mala [1 ]
Pallett, Laura J. [1 ]
机构：
[1] UCL, Infect & Immun, London, England
[2] Gilead Sci, Foster City, CA USA
[3] UCL, Infect Immun & Transplantat, London, England
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)30877-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-132
引用
收藏
页码：E445 / E445
页数：1
相关论文
共 50 条
  • [1] Therapeutic Potential of TLR8 Agonist GS-9688 (Selgantolimod) in Chronic Hepatitis B: Remodeling of Antiviral and Regulatory Mediators
    Amin, Oliver E.
    Colbeck, Emily J.
    Daffis, Stephane
    Khan, Shahzada
    Ramakrishnan, Dhivya
    Pattabiraman, Divya
    Chu, Ruth
    Steuer, Holly Micolochick
    Lehar, Sophie
    Peiser, Leanne
    Palazzo, Adam
    Frey, Christian
    Davies, Jessica
    Javanbakht, Hassan
    Rosenberg, William M. C.
    Fletcher, Simon P.
    Maini, Mala K.
    Pallett, Laura J.
    [J]. HEPATOLOGY, 2021, 74 (01) : 55 - 71
  • [2] Discovery of the selective TLR8 agonist GS-9688 for HBV cure
    Mish, Michael
    Chin, Gregory
    Aktoudianakis, Vangelis
    Metobo, Sammy
    Pyun, Hyung-Jung
    Villasenor, Armando
    Appleby, Todd
    Perry, Jason
    Daffis, Stephane
    Ramakrishnan, Dhivya
    Niu, Congrong
    Zheng, Jim
    Santos, Rex
    Yu, Helen
    Lee, Gary
    Palazzo, Adam
    Frey, Christian
    Pflanz, Stefan
    Delaney, William
    Fletcher, Simon
    Mackman, Richard
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [3] Cytokine-dependent activation of MAIT cells by the TLR8 agonist GS-9688 but not the TLR7 agonist GS-9620
    Daffis, S.
    Morar, M.
    Pattabiraman, D.
    Voitenleitner, C.
    Fletcher, S.
    Javanbakht, H.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 : S800 - S800
  • [4] PERIPHERAL IMMUNE RESPONSES TO TOLL-LIKE RECEPTOR 8 AGONIST GS-9688 IN PATIENTS WITH CHRONIC HEPATITIS B
    Brooks, Anna E.
    Verdon, Daniel
    Eom, Jennifer
    Ng, Jin
    Steemson, John
    Lau, Audrey H.
    Wallin, Jeffrey
    Gaggar, Anuj
    Kottilil, Shyam
    Poonia, Bhawna
    Dunbar, Rod
    [J]. HEPATOLOGY, 2019, 70 : 440A - 441A
  • [5] Safety, Pharmacokinetics and Pharmacodynamics of Oral TLR8 Agonist GS-9688 in Patients with Chronic Hepatitis B: A Randomized, Placebo-Controlled, Double-Blind Phase 1b Study
    Gane, Edward J.
    Kim, Hyung Joon
    Visvanathan, Kumar
    Kim, Yoon Jun
    Nguyen, Anh-Hoa
    Joshi, Adarsh
    Reyes, Maribel
    Lau, Audrey H.
    Gaggar, Anuj
    Subramanian, Mani
    Roberts, Stuart Keith
    Lim, Young-Suk
    [J]. HEPATOLOGY, 2018, 68 : 238A - 239A
  • [6] Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B
    Daffis, Stephane
    Balsitis, Scott
    Chamberlain, Jason
    Zheng, Jim
    Santos, Rex
    Rowe, William
    Ramakrishnan, Dhivya
    Pattabiraman, Divya
    Spurlock, Sandra
    Chu, Ruth
    Kang, Don
    Mish, Michael
    Ramirez, Ricardo
    Li, Li
    Li, Bei
    Ma, Sarina
    Hung, Magdeleine
    Voitenleitner, Christian
    Yon, Changsuek
    Suresh, Manasa
    Menne, Stephan
    Cote, Paul
    Delaney, William E.
    Mackman, Richard
    Fletcher, Simon P.
    [J]. HEPATOLOGY, 2021, 73 (01) : 53 - 67
  • [7] GS-9688, a Toll-like Receptor 8 Agonist Induces Innate and Adaptive Antiviral Immune Response in Chronic Hepatitis B Patients
    Khanam, Arshi
    Yoon, Ji Ae
    Poonia, Bhawna
    Grant, Ethan
    Kottilil, Shyamasundaran
    Tang, Lydia
    [J]. HEPATOLOGY, 2018, 68 : 329A - 330A
  • [8] Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B
    Mackman, Richard L.
    Mish, Michael
    Chin, Gregory
    Perry, Jason K.
    Appleby, Todd
    Aktoudianakis, Vangelis
    Metobo, Sammy
    Pyun, Peter
    Niu, Congrong
    Daffis, Stephane
    Yu, Helen
    Zheng, Jim
    Villasenor, Armando G.
    Zablocki, Jeff
    Chamberlain, Jason
    Jin, Haolun
    Lee, Gary
    Suekawa-Pirrone, Kimberley
    Santos, Rex
    Delaney, William E.
    Fletcher, Simon P.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (18) : 10188 - 10203
  • [9] EFFICACY AND SAFETY OF ORAL TLR8 AGONIST GS-9688 IN VIRALLY-SUPPRESSED ADULT PATIENTS WITH CHRONIC HEPATITIS B: A PHASE 2, RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED, MULTI-CENTER STUDY
    Gane, Edward J.
    Zhao, Yang
    Tan, Susanna
    Lau, Audrey H.
    Gaggar, Anuj
    Subramanian, Mani
    Kottilil, Shyam
    Tang, Lydia
    [J]. HEPATOLOGY, 2019, 70 : 435A - 436A
  • [10] In vitro and in vivo characterization of the selective toll-like receptor 8 agonist GS-9688
    Daffis, S.
    Ramakrishnan, D.
    Niu, C.
    Zheng, J.
    Santos, R.
    Mish, M.
    Chin, G.
    Aktoudianakis, V.
    Metobo, S.
    Pyun, H-J
    Yu, H.
    Lee, G.
    Palazzo, A.
    Frey, C.
    Pflanz, S.
    Delaney, W. E.
    Fletcher, S. P.
    Mackman, R.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S694 - S694
12345